Prostate Cancer - Results from #23720

Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective - Abstract March 2, 2013

Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance - Abstract March 2, 2013

Fostering informed decisions: A randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer - Abstract March 1, 2013

Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer - Abstract March 1, 2013

Management of castration-resistant prostate cancer: A global approach - Abstract March 1, 2013

Salvage radiotherapy outcomes for biochemical recurrence following radical prostatectomy among the African-Caribbean population of Guadeloupe - Abstract March 1, 2013

Assays for prostate cancer: Changing the screening paradigm? - Abstract March 1, 2013

Androgen deprivation therapy in advanced prostate cancer: Is intermittent therapy the new standard of care? - Abstract March 1, 2013

Targeting the androgen receptor in the management of castration-resistant prostate cancer: Rationale, progress, and future directions - Abstract March 1, 2013

The importance of local control in high-risk locally advanced prostate cancer - Abstract March 1, 2013

Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy - Abstract March 1, 2013

Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer - Abstract March 1, 2013

Targeting the apoptosis pathway in prostate cancer - Abstract February 28, 2013

GU Cancers Symposium 2013 - Evolving patterns of metastatic disease in castration resistant prostate cancer reported in clinical trials from 1990 to 2011, by William K. Oh, MD, et al. - Session Highlights February 28, 2013

GU Cancers Symposium 2013 - Poster: Evolving patterns of metastatic disease in castration resistant prostate cancer reported in clinical trials from 1990 to 2011, by William K. Oh, MD, et al. February 28, 2013

Bone-targeting radiopharmaceuticals including radium-223 - Abstract February 27, 2013

Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer - Abstract February 27, 2013

Association between use of β-blockers and prostate cancer-specific survival: A cohort study of 3561 prostate cancer patients with high-risk or metastatic disease - Abstract February 27, 2013

Metabolic syndrome and insulin resistance in patients with prostate cancer treated with androgen deprivation hormone - Abstract February 27, 2013

Prostate cancer and osteoporosis - Abstract February 27, 2013

Page 1187 of 1436